Advertisement

Effects of coenzyme Q10 on vascular endothelial function in humans: A meta-analysis of randomized controlled trials

  • Author Footnotes
    d Both authors contributed equally to this work.
    Linggen Gao
    Footnotes
    d Both authors contributed equally to this work.
    Affiliations
    Department of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Search for articles by this author
  • Author Footnotes
    d Both authors contributed equally to this work.
    Qunxia Mao
    Footnotes
    d Both authors contributed equally to this work.
    Affiliations
    National Research Institute for Family Planning, Beijing 100081, China
    Search for articles by this author
  • Jian Cao
    Affiliations
    Department of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Search for articles by this author
  • Yutang Wang
    Affiliations
    Department of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Search for articles by this author
  • Xianliang Zhou
    Correspondence
    Corresponding author. Tel.: +86 10 8839 8056; fax: +86 10 8839 8358.
    Affiliations
    Department of Cardiology, FuWai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China
    Search for articles by this author
  • Li Fan
    Correspondence
    Corresponding author. Tel.: +86 10 6693 9103; fax: +86 10 6693 9103.
    Affiliations
    Department of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Search for articles by this author
  • Author Footnotes
    d Both authors contributed equally to this work.

      Abstract

      Objective

      The purpose of this study was to quantify the effect of coenzyme Q10 on arterial endothelial function in patients with and without established cardiovascular disease.

      Background

      Endothelial dysfunction has been implicated in the pathogenesis of atherosclerosis.

      Methods and results

      The search included MEDLINE, Cochrane Library, Scopus, and EMBASE to identify studies up to 1 July 2011. Eligible studies were randomized controlled trials on the effects of coenzyme Q10 compared with placebo on endothelial function. Two reviewers extracted data on study characteristics, methods, and outcomes. Five eligible trials enrolled a total of 194 patients. Meta-analysis using random-effects model showed treatment with coenzyme Q10 significantly improvement in endothelial function assessed peripherally by flow-mediated dilatation (SMD 1.70, 95% CI: 1.00–2.4, p < 0.0001). However, the endothelial function assessed peripherally by nitrate-mediated arterial dilatation was not significantly improved by using fix-effects model (SMD −0.19, 95% CI: −1.75 to 1.38, p = 0.81).

      Conclusion

      Coenzyme Q10 supplementation is associated with significant improvement in endothelial function. The current study supports a role for CoQ10 supplementation in patients with endothelial dysfunction.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Libby P.
        • Theroux P.
        Pathophysiology of coronary artery disease.
        Circulation. 2005; 111: 3481-3488
        • Tousoulis D.
        • Antoniades C.
        • Tentolouris C.
        • Goumas G.
        • Stefanadis C.
        • Toutouzas P.
        l-Arginine in cardiovascular disease: dream or reality?.
        Vasc Med. 2002; 7: 203-211
        • Schachinger V.
        • Britten M.B.
        • Zeiher A.M.
        Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
        Circulation. 2000; 101: 1899-1906
        • Landmesser U.
        • Hornig B.
        • Drexler H.
        Endothelial function: a critical determinant in atherosclerosis?.
        Circulation. 2004; 109: II27-II33
        • Celermajer D.S.
        • Sorensen K.E.
        • Bull C.
        • Robinson J.
        • Deanfield J.E.
        Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.
        J Am Coll Cardiol. 1994; 24: 1468-1474
        • Ludmer P.L.
        • Selwyn A.P.
        • Shook T.L.
        • et al.
        Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.
        N Engl J Med. 1986; 315: 1046-1051
        • Reddy K.G.
        • Nair R.N.
        • Sheehan H.M.
        • Hodgson J.M.
        Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis.
        J Am Coll Cardiol. 1994; 23: 833-843
        • Kitta Y.
        • Obata J.E.
        • Nakamura T.
        • et al.
        Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease.
        J Am Coll Cardiol. 2009; 53: 323-330
        • Modena M.G.
        • Bonetti L.
        • Coppi F.
        • Bursi F.
        • Rossi R.
        Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women.
        J Am Coll Cardiol. 2002; 40: 505-510
        • Finckh B.
        • Kontush A.
        • Commentz J.
        • Hubner C.
        • Burdelski M.
        • Kohlschutter A.
        High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol 10, ubiquinone 10, carotenoids, and tocopherols in neonatal plasma.
        Methods Enzymol. 1999; 299: 341-348
        • Langsjoen P.H.
        • Vadhanavikit S.
        • Folkers K.
        Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
        Proc Natl Acad Sci U S A. 1985; 82: 4240-4244
        • Niklowitz P.
        • Sonnenschein A.
        • Janetzky B.
        • Andler W.
        • Menke T.
        Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage.
        Int J Biol Sci. 2007; 3: 257-262
        • Baggio E.
        • Gandini R.
        • Plancher A.C.
        • Passeri M.
        • Carmosino G.
        Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure CoQ10 Drug Surveillance Investigators.
        Mol Aspects Med. 1994; 15: s287-s294
        • Mortensen S.A.
        Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of Q-symbio—a multinational trial.
        Biofactors. 2003; 18: 79-89
        • Langsjoen P.H.
        • Langsjoen A.M.
        Supplemental ubiquinol in patients with advanced congestive heart failure.
        Biofactors. 2008; 32: 119-128
        • Hughes K.
        • Lee B.L.
        • Feng X.
        • Lee J.
        • Ong C.N.
        Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese.
        Free Radic Biol Med. 2002; 32: 132-138
        • Burke B.E.
        • Neuenschwander R.
        • Olson R.D.
        Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension.
        South Med J. 2001; 94: 1112-1117
        • Rosenfeldt F.L.
        • Haas S.J.
        • Krum H.
        • et al.
        Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.
        J Hum Hypertens. 2007; 21: 297-306
        • Ho M.J.
        • Bellusci A.
        • Wright J.M.
        Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
        Cochrane Database Syst Rev. 2009; 2009 (CD007): 435
        • Tiano L.
        • Belardinelli R.
        • Carnevali P.
        • Principi F.
        • Seddaiu G.
        • Littarru G.P.
        Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
        Eur Heart J. 2007; 28: 2249-2255
        • Belardinelli R.
        • Mucaj A.
        • Lacalaprice F.
        • et al.
        Coenzyme Q10 and exercise training in chronic heart failure.
        Eur Heart J. 2006; 27: 2675-2681
        • Hamilton S.J.
        • Chew G.T.
        • Watts G.F.
        Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
        Diabetes Care. 2009; 32: 810-812
        • Higgins J.P.
        • White I.R.
        • Wood A.M.
        Imputation methods for missing outcome data in meta-analysis of clinical trials.
        Clin Trials. 2008; 5: 225-239
        • Follmann D.
        • Elliott P.
        • Suh I.
        • Cutler J.
        Variance imputation for overviews of clinical trials with continuous response.
        J Clin Epidemiol. 1992; 45: 769-773
        • de Bree A.
        • van Mierlo L.A.
        • Draijer R.
        Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials.
        Am J Clin Nutr. 2007; 86: 610-617
        • Verhagen A.P.
        • de Vet H.C.
        • de Bie R.A.
        • et al.
        The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.
        J Clin Epidemiol. 1998; 51: 1235-1241
        • Mantel N.
        • Haenszel W.
        Statistical aspects of the analysis of data from retrospective studies of disease.
        J Natl Cancer Inst. 1959; 22: 719-748
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Raitakari O.T.
        • McCredie R.J.
        • Witting P.
        • et al.
        Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults.
        Free Radic Biol Med. 2000; 28: 1100-1105
        • Watts G.F.
        • Playford D.A.
        • Croft K.D.
        • Ward N.C.
        • Mori T.A.
        • Burke V.
        Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes mellitus.
        Diabetologia. 2002; 45: 420-426
        • Dai Y.L.
        • Luk T.H.
        • Yiu K.H.
        • et al.
        Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial.
        Atherosclerosis. 2011; 216: 395-401
        • Neunteufl T.
        • Heher S.
        • Katzenschlager R.
        • et al.
        Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain.
        Am J Cardiol. 2000; 86: 207-210
        • Shimbo D.
        • Grahame-Clarke C.
        • Miyake Y.
        • et al.
        The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort.
        Atherosclerosis. 2007; 192: 197-203
        • Moens A.L.
        • Goovaerts I.
        • Claeys M.J.
        • Vrints C.J.
        Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?.
        Chest. 2005; 127: 2254-2263
      1. Tsai KL, Huang YH, Kao CL, et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem 2011; [Epub ahead of print].

        • Kalen A.
        • Appelkvist E.L.
        • Dallner G.
        Age-related changes in the lipid compositions of rat and human tissues.
        Lipids. 1989; 24: 579-584
        • Beal M.F.
        Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease.
        Parkinsonism Relat Disord. 2009; 15: S189-S194
        • Kumar A.
        • Kaur H.
        • Devi P.
        • Mohan V.
        Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome.
        Pharmacol Ther. 2009; 124: 259-268
        • Pepe S.
        • Marasco S.F.
        • Haas S.J.
        • Sheeran F.L.
        • Krum H.
        • Rosenfeldt F.L.
        Coenzyme Q10 in cardiovascular disease.
        Mitochondrion. 2007; 7: S154-S167
        • Alleva R.
        • Tomasetti M.
        • Battino M.
        • Curatola G.
        • Littarru G.P.
        • Folkers K.
        The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions.
        Proc Natl Acad Sci U S A. 1995; 92: 9388-9391
        • Kaikkonen J.
        • Nyyssonen K.
        • Tomasi A.
        • et al.
        Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study.
        Free Radic Res. 2000; 33: 329-340
        • Lim S.C.
        • Lekshminarayanan R.
        • Goh S.K.
        • et al.
        The effect of coenzyme Q10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus.
        Atherosclerosis. 2008; 196: 966-969
        • Montecucco F.
        • Mach F.
        Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
        Rheumatology (Oxford). 2009; 48: 11-22
        • Hansson G.K.
        • Libby P.
        The immune response in atherosclerosis: a double-edged sword.
        Nat Rev Immunol. 2006; 6: 508-519
        • Hahn B.H.
        • Grossman J.
        • Chen W.
        • McMahon M.
        The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
        J Autoimmun. 2007; 28: 69-75
        • Bentinger M.
        • Tekle M.
        • Dallner G.
        Coenzyme Q—biosynthesis and functions.
        Biochem Biophys Res Commun. 2010; 396: 74-79
        • Schmelzer C.
        • Lindner I.
        • Vock C.
        • Fujii K.
        • Doring F.
        Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study.
        IUBMB Life. 2007; 59: 628-633
        • Schmidt A.J.
        • Heiser P.
        • Hemmeter U.M.
        • Krieg J.C.
        • Vedder H.
        Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells.
        Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1567-1573
        • Rowe G.C.
        • Jiang A.
        • Arany Z.
        PGC-1 coactivators in cardiac development and disease.
        Circ Res. 2010; 107: 825-838